Drug recall · February 20, 2013
Lac-Hydrin recall
Why: Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lac-Hydrin (ammonium lactate) Lotion, 12%, packaged in 400 g bottles, Rx only, Ranbaxy, Jacksonville, FL 32257 USA, NDC 10631-098-14.
- Lots / codes
Lot #: RB93911, Exp 07/14
- Quantity
- 4,016 bottles
- Company
- Ranbaxy Inc., Princeton, NJ
- Distribution
- Nationwide and Puerto Rico
- Initiated
- December 27, 2012 · Voluntary: Firm initiated
- Classified
- February 12, 2013
- Reported
- February 20, 2013
- Ended
- April 9, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lactate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.